JMIR Publications invites submissions to a new section on “Algorithmic Parenting: The Rise of Data-Driven Child-Rearing” in its open access journal JMIR Pediatrics and Parenting.

A multidisciplinary study has uncovered a critical component in the formation of biofilms, the complex structures used by bacteria to colonise surfaces. The research may have implications for future infection treatments, including for people with cystic fibrosis. 

A flexible sensing-storage integrated system have been developed for wearable health monitoring. This system is fabricated using a low-cost solution spin-coating process, combining a flexible floating-gate organic thin-film transistor memory with an organic thin-film transistor pressure sensor to achieve in-situ acquisition and storage of physiological signals, which provides an innovative platform for constructing low-cost, fully flexible electronic skins capable of simultaneous physiological sensing, data storage, and wireless transmission.

The project highlights evidence and practical applications related to conditions that often share common underlying drivers, including type 2 diabetes, hypertension and obesity.

FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico’s first FTD, recognizing the clinical potential in advanced mesothelioma.

ISM6331 is a novel, potential best-in-class, pan-TEAD inhibitor engineered via Chemistry42 to restore Hippo pathway balance, and its Phase I first-in-human data has been accepted for a brief oral presentation at ESMO 2026.

The FTD grants ISM6331 enhanced FDA engagement to accelerate the clinical development processes, alongside eligibility for Rolling Review, Accelerated Approval, and Priority Review, if relevant criteria are met.

An overactive immune response in the brain may play a role in Dravet Syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers. Children with the condition experience frequent seizures that are often difficult to control with medication and may also face developmental, cognitive and behavioral challenges. Until now, most research has focused on how a mutation in the SCN1A gene disrupts electrical signaling in the brain.